Crescent Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CBIO and other ETFs, options, and stocks.

About CBIO

Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA. 

CEO
Joshua T. Brumm
CEOJoshua T. Brumm
Employees
44
Employees44
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2024
Founded2024
Employees
44
Employees44

CBIO Key Statistics

Market cap
478.37M
Market cap478.37M
Price-Earnings ratio
-1.38
Price-Earnings ratio-1.38
Dividend yield
Dividend yield
Average volume
319.08K
Average volume319.08K
High today
$18.34
High today$18.34
Low today
$17.11
Low today$17.11
Open price
$18.00
Open price$18.00
Volume
238.26K
Volume238.26K
52 Week high
$27.41
52 Week high$27.41
52 Week low
$8.72
52 Week low$8.72

Stock Snapshot

As of today, Crescent Biopharma(CBIO) shares are valued at $17.28. The company's market cap stands at 478.37M, with a P/E ratio of -1.38.

During the trading session on 2026-06-09, Crescent Biopharma(CBIO) shares reached a daily high of $18.34 and a low of $17.11. At a current price of $17.28, the stock is +1.0% higher than the low and still -5.8% under the high.

Trading activity shows a volume of 238.26K, compared to an average daily volume of 319.08K.

Over the past 52 weeks, Crescent Biopharma(CBIO) stock has traded between a high of $27.41 and a low of $8.72.

Over the past 52 weeks, Crescent Biopharma(CBIO) stock has traded between a high of $27.41 and a low of $8.72.

CBIO News

TipRanks 11h
Why IDEAYA Biosciences Shares Are Tumbling Now - TipRanks

...

Why IDEAYA Biosciences Shares Are Tumbling Now - TipRanks
TipRanks 6d
Crescent Biopharma shareholders back directors, pay and auditor

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

People also own

Based on the portfolios of people who own CBIO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.